Iovance Biotherapeutics Inc. (0JDK)
LSE
Real-time Data
07:00 AM
Day's Range
12.9252 wk Range
1.76Overview - 0JDK - Iovance Biotherapeutics Inc.
Key Statistics
Valuation
Enterprise Value
6.19B
P/E (Trailing)
‪25.49‬
PEG Ratio
‪0.22‬
Price / Sales (TTM)
‪5.69‬
Price / Book
‪8.75‬
EV / EBITDA
‪-23.86‬
Profitability
Gross Margin
‪74.72%‬
Profit Margin
‪-89.09%‬
Operating Margin
‪-52.26%‬
Return on Assets
‪-20.30%‬
Return on Equity
‪-40.36%‬
Ownership
Shares Outstanding
123.17M
Float
394.31M
Held by Insiders
‪0.35%‬
Held by Institutions
‪70.66%‬
Price stats
Beta
‪0.83‬
50-Day Avg
‪11.04‬
200-Day Avg
‪7.44‬
Dividends
Frequency
Quarterly
Market Cap - 0JDK - Iovance Biotherapeutics Inc.
Peers - 0JDK - Iovance Biotherapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0JDKLSEIovance Biotherapeutics Inc.1.75BMarket Cap+84.26%52-week change25.49P/E (Trailing)‪-89.09%‬Profit Margin
- 0MGBLSEGenmab A/S198.39BMarket Cap+15.12%52-week change33.69P/E (Trailing)‪29.01%‬Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated Common Stock128.96BMarket Cap+20.00%52-week change0.53P/E (Trailing)‪34.99%‬Profit Margin
- 0A45LSEModerna Inc.95.05BMarket Cap+87.31%52-week change72.95P/E (Trailing)‪11.32%‬Profit Margin
- 0R2MLSERegeneron Pharmaceuticals, Inc.79.08BMarket Cap+20.99%52-week change0.11P/E (Trailing)‪27.86%‬Profit Margin
- 0QW0LSEargenx SE49.68BMarket Cap+27.60%52-week change40.07P/E (Trailing)‪-47.51%‬Profit Margin
- 0NZTLSEUCB SA41.70BMarket Cap-23.88%52-week change120.47P/E (Trailing)‪6.45%‬Profit Margin
Profile Summary - 0JDK - Iovance Biotherapeutics Inc.
About
Iovance Biotherapeutics is a commercial-stage biopharmaceutical company pioneering the development and commercialization of tumor-infiltrating lymphocyte (TIL) cell therapies for patients with solid tumor cancers. The company's approach harnesses the immune system's natural ability to recognize and attack cancer cells…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
